Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

1 results
1:03 PM, Dec 08, 2017  |  BC Week In Review | Company News  |  Deals

Newco Ayala in-licenses BMS gamma secretase inhibitors

Co. (NYSE:BMY) granted newco Ayala Pharmaceuticals Inc. (Rehovot, Israel) exclusive, worldwide rights to BMS-906024 and BMS-986115
adenoid cystic carcinoma and an undisclosed Orphan indication. Gelbaum declined to disclose next steps for BMS-986115
which has completed Phase Ib testing. BMS-906024 is administered by IV, while BMS-986115 is an oral …